Paper3872052
Comparative electrophysiologic profiles of calcium antagonists with particular reference to bepridil.
Singh BN and 4 others. Am J Cardiol, 1985. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Comparative electrophysiologic profiles of calcium antagonists with particular reference to bepridil. Papers, record 3872052. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3872052
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arrhythmias, Cardiac | Major topic |
| Calcium Channel Blockers | Major topic |
| Heart Conduction System | Major topic |
| Pyrrolidines | Major topic |
| Adult | |
| Aged | |
| Atrioventricular Node | |
| Bepridil | |
| Cardiac Pacing, Artificial | |
| Electrocardiography | |
| Electrophysiology | |
| Humans | |
| Male | |
| Middle Aged | |
| Sinoatrial Node | |
| Verapamil |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 3530295 | The mechanism of action of calcium antagonists relative to their clinical applications. | Br J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3530295 | PubMed |
| 3260528 | Effects of bepridil on ventricular depolarization and repolarization of rabbit isolated hearts with particular reference to its possible proarrhythmic properties. | Br J Pharmacol | 1988 | https://conductscience.org/library/papers/3260528 | PubMed |
| 2804541 | Comparative effects of bepridil, its quaternary derivative CERM 11888 and verapamil on caffeine-induced contracture in ferret hearts. | Br J Pharmacol | 1989 | https://conductscience.org/library/papers/2804541 | PubMed |
| 2611495 | Electrophysiological effects of bepridil and its quaternary derivative CERM 11888 in closed chest anaesthetized dogs: a comparison with verapamil and diltiazem. | Br J Pharmacol | 1989 | https://conductscience.org/library/papers/2611495 | PubMed |
| 2475788 | Effects of the calcium entry blocker bepridil on repolarizing and pacemaker currents in sheep cardiac Purkinje fibres. | Naunyn Schmiedebergs Arch Pharmacol | 1989 | https://conductscience.org/library/papers/2475788 | PubMed |
| 1854661 | QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards. | Cardiovasc Drugs Ther | 1991 | https://conductscience.org/library/papers/1854661 | PubMed |
| 1321957 | Antiarrhythmic and electrophysiological effects of SD-3212, a novel Na+ and Ca++ channel blocker, in anaesthetized dogs with myocardial infarction in comparison with its stereoisomer (SD-3211) and bepridil. | Naunyn Schmiedebergs Arch Pharmacol | 1992 | https://conductscience.org/library/papers/1321957 | PubMed |
| 1280569 | Bepridil. A review of its pharmacological properties and therapeutic use in stable angina pectoris. | Drugs | 1992 | https://conductscience.org/library/papers/1280569 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3872052
GET https://conductscience.org/api/papers/v1/3872052/authors